The lead off
- Ohio advocacy group asks federal prosecutors to investigate mail-order abortion medication providers
- Request cites federal Comstock Act as legal basis for potential enforcement
- Issue comes as U.S. Supreme Court allows telehealth abortion access to continue during ongoing litigation
COLUMBUS, OH (WOWO) An Ohio-based religious advocacy organization is calling on federal prosecutors to investigate providers of mail-order abortion medications, citing a federal law that restricts the mailing of abortion-related drugs.
Letter sent to federal prosecutors
The Columbus-based Center for Christian Virtue sent a letter to U.S. Attorneys Dominick Gerace II and David M. Toepfer, urging enforcement of the federal Comstock Act as it relates to the interstate mailing of mifepristone and other abortion-related medications.
According to the letter, the group asked prosecutors to “open investigative inquiries into mail-order abortion providers knowingly shipping mifepristone,” coordinate with the U.S. Postal Inspection Service, and pursue prosecution where applicable.
Aaron Baer, president of the Center for Christian Virtue, wrote that federal prosecutors have historically exercised discretion in not enforcing those provisions, but said that discretion “does not mean abdication.”
Comstock Act at the center of argument
The Comstock Act, passed in 1873, originally prohibited the mailing of “obscene” materials and items intended to produce abortion. Portions of the law have been modified over time, including changes following Supreme Court decisions and federal policy shifts.
The group argues the statute remains enforceable and applies to modern mail-order distribution of abortion medication, including mifepristone according to the Ohio Capital Journal.
Baer wrote in the letter that the law “does not contain an exception for FDA-approved drugs, for physician supervision, or for states that have chosen to permit abortion.”
Supreme Court action and ongoing legal context
The request comes as the U.S. Supreme Court has not blocked telehealth distribution of abortion medication while it considers a separate case out of Louisiana involving access to mifepristone.
A recent dissent from Justice Clarence Thomas referenced the Comstock Act, suggesting the statute could be relevant to the legality of mailing abortion drugs. Justice Samuel Alito also issued a separate dissent raising related concerns.
Medication abortion, typically involving mifepristone and misoprostol, has become increasingly common in the United States, including in Ohio, according to state health data cited in reporting.
Supporters and opponents react
Abortion rights advocacy group Abortion Forward criticized the letter, arguing that efforts to restrict telehealth access do not reflect public sentiment in Ohio.
Executive Director Kellie Copeland said in a statement that “Ohioans do not find it obscene to access safe and effective medication from trusted healthcare providers via telemedicine,” and described the lobbying effort as interference in medical decision-making.
The U.S. Attorney’s Offices in Ohio have not publicly commented on the letter, according to reporting.
Forward outlook
The request places renewed attention on how federal prosecutors interpret and potentially enforce the Comstock Act as litigation over abortion medication access continues before the U.S. Supreme Court. Any decision to investigate or pursue enforcement action would likely depend on further legal guidance from federal courts and administrative review.
The takeaway
- The Center for Christian Virtue is urging federal prosecutors in Ohio to investigate mail-order providers of abortion medication, citing the Comstock Act as legal authority.
- The U.S. Supreme Court is currently considering related litigation while leaving existing telehealth abortion access rules in place.
- The request highlights ongoing legal and political disputes over medication abortion, with advocates on both sides pointing to differing interpretations of federal law and public policy.
